Itf Research Pharma, S.l.u.

Italfarmaco, Sa

Dolores Blanco Lousame

Jaime Moscoso Del Prado

Álvaro Acebrón Fernández

Alvaro Acebron Fernandez

Concepción Nieto Magro

Concepcion Nieto Magro

ÁIvaro ACEBRÓN FERNÁNDEZ

Cándida Gascó Guerrero

The present invention relates to the use of estriol in the preparation of a pharmaceutical formulation for vaginal administration with the capacity to self-limit the absorption of estriol, for the prevention and/or the treatment of urogenital atrophy in women, said women having a high probability of developing an estrogen-dependent tumor or suffering or having suffered from an estrogen-dependent tumor.

Treatment of vaginal atrophy in women with tumor pathology risk

The present invention relates to the use of estriol in the preparation of a pharmaceutical formulation for vaginal administration with the capacity to self-limit the absorption of estriol, for the prevention and/or the treatment of urogenital atrophy in women said women having a high probability of suffering from a cardiovascular pathology or suffering or having suffered from a cardiovascular pathology.

Treatment of vaginal atrophy in women with cardiovascular pathology risk

The invention relates to the use of low doses of estriol by vaginal route for treatment and/or prevention of urogenital atrophy due to estrogen deficit in women.

Use of estriol in low doses

Growing community of inventors

Madrid, Spain

Dolores Blanco Lousame